Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEvaxion Biotech A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q2 2025 | 1 | -$0.45 | -$0.45 | -$0.45 |
| Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q1 2026 | 1 | $0.05 | $0.05 | $0.05 |
| Q2 2026 | 1 | $0.20 | $0.20 | $0.20 |
| Q3 2026 | 1 | $0.21 | $0.21 | $0.21 |
| Q4 2026 | 1 | $0.23 | $0.23 | $0.23 |
Evaxion Biotech A/S Earnings Date And Information
Evaxion Biotech A/S last posted its earnings results on Thursday, October 31st, 2024. The company reported $-0.2 earnings per share for the quarter, topping analysts' consensus estimates of $-0.6 by $0.4. The company had revenue of 3.03 M for the quarter and had revenue of 73,000 for the year. Evaxion Biotech A/S has generated $-2 earnings per share over the last year ($-1.622 diluted earnings per share) and currently has a price-to-earnings ratio of -0.22. Evaxion Biotech A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based on prior year's report dates.
Evaxion Biotech A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2024 | Q3 2024 | N/A | -$0.07 | N/A | $123,333 | $3.03 M |
| 06/28/2024 | Q2 2024 | N/A | -$0.23 | N/A | $52,000 | $153,887 |
| 08/14/2024 | Q1 2024 | $0.10 | $0.05 | -0.05 | N/A | $50,881 |
| 03/26/2024 | Q4 2023 | N/A | -$0.33 | N/A | N/A | $73,597 |
| 09/07/2023 | Q3 2023 | N/A | -$0.41 | N/A | N/A | $0 |
| 08/17/2023 | Q2 2023 | N/A | -$0.42 | N/A | N/A | $0 |
| 08/17/2023 | Q1 2023 | N/A | -$0.48 | N/A | N/A | $0 |
| 04/27/2023 | Q4 2022 | N/A | -$0.57 | N/A | N/A | $0 |
| 04/27/2023 | Q3 2022 | N/A | -$0.48 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.41 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.50 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2021 | N/A | -$0.77 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$0.55 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$0.72 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$0.46 | N/A | N/A | $0 |
| 04/07/2021 | Q4 2020 | N/A | -$0.53 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | -$0.50 | N/A | N/A | $0 |
| 06/30/2020 | Q2 2020 | N/A | -$0.38 | N/A | N/A | $0 |
| 03/31/2020 | Q1 2020 | N/A | -$0.32 | N/A | N/A | $0 |
| 12/31/2019 | Q4 2019 | N/A | -$0.37 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Evaxion Biotech A/S Earnings: FAQ's
Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 25th, 2025 based offlast year's report dates.
In the previous quarter, Evaxion Biotech A/S (:EVAX) reported $-0.2 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.6 by $0.4.
The conference call for Evaxion Biotech A/S's latest earnings report can be listened to online.
The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online.
Evaxion Biotech A/S (:EVAX) has a recorded annual revenue of $73,000.
Evaxion Biotech A/S (:EVAX) has a recorded net income of $-22,125,000.Evaxion Biotech A/S has generated $-1.622 earnings per share over the last four quarters.
Evaxion Biotech A/S (:EVAX) has a price-to-earnings ratio of -0.22 and price/earnings-to-growth ratio is -0.01.